Magenta Therapeutics
Utility Patent Applications

Last updated:

List of all Magenta Therapeutics patents 40 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES External link
Filling date: 6 Sep 2025 Issue date: 1 Sep 2022
Application
Utility: ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: T-CELL DEPLETING THERAPIES External link
Filling date: 6 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: ANTHRACYCLINE ANTIBODY-DRUG CONJUGATES AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 21 Jul 2022
Application
Utility: ANTI-CD117 ANTIBODIES AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: ANTI-CD117 ANTIBODIES AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: Anti-CD45 Antibody Drug Conjugates and Uses Thereof External link
Filling date: 6 Sep 2025 Issue date: 9 Jun 2022
Application
Utility: DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS External link
Filling date: 6 Sep 2025 Issue date: 31 Mar 2022
Application
Utility: USE OF AN ANTI-CD45 ANTIBODY DRUG CONJUGATE (ADC) IN CELL THERAPY External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: METHODS FOR HEMATOPOIETIC STEM AND PROGENITOR CELL TRANSPLANT THERAPY External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS External link
Filling date: 6 Sep 2025 Issue date: 9 Dec 2021
Application
Utility: ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 2 Dec 2021
Application
Utility: USE OF ANTI-CD5 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL THERAPY External link
Filling date: 6 Sep 2025 Issue date: 18 Nov 2021
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 14 Oct 2021
Application
Utility: THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCS) External link
Filling date: 6 Sep 2025 Issue date: 16 Sep 2021
Application
Utility: USE OF AN ANTI-CD2 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL THERAPY External link
Filling date: 6 Sep 2025 Issue date: 26 Aug 2021
Application
Utility: USE OF ANTI-CD137 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL THERAPY External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 22 Jul 2021
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 8 Jul 2021
Application
Utility: ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 3 Jun 2021
Application
Utility: MODIFIED ANTIBODIES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 13 May 2021
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD134+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 8 Apr 2021
Application
Utility: ANTI-CD252 ANTIBODIES, CONJUGATES, AND METHODS OF USE External link
Filling date: 6 Sep 2025 Issue date: 1 Apr 2021
Application
Utility: AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 31 Dec 2020
Application
Utility: ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS External link
Filling date: 6 Sep 2025 Issue date: 17 Dec 2020
Application
Utility: FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS External link
Filling date: 6 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS AND TREATMENT OF INHERITED METABOLIC DISORDERS External link
Filling date: 6 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS External link
Filling date: 6 Sep 2025 Issue date: 3 Sep 2020
Application
Utility: FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: COMPOSITIONS AND METHODS FOR HEMATOPOIETIC STEM AND PROGENITOR CELL TRANSPLANT THERAPY External link
Filling date: 6 Sep 2025 Issue date: 14 Nov 2019
Application
Utility: DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS External link
Filling date: 6 Sep 2025 Issue date: 7 Nov 2019
Application
Utility: COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS External link
Filling date: 6 Sep 2025 Issue date: 31 Oct 2019
Application
Utility: COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS External link
Filling date: 6 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS External link
Filling date: 6 Sep 2025 Issue date: 5 Sep 2019

Showing 1 to 40 of 40 patents.